Skip to main content
. 2009 Oct 6;101(11):1807–1812. doi: 10.1038/sj.bjc.6605349

Table 1. Fcγ-receptors in human and mouse.

    Activatory Relative Structural signalling Allelic Putative functional murine Principal effector-cell expression profilea
Receptor CD inhibitory affinity for IgG components variants analogue mΦ DC N B NK
Human
 FcγRI CD64 Activatory Highb ITAM (associated γ-chain)   FcγRI    
 Fcγ RIIa CD32a Activatory Low/Mod ITAM (integral) 131H 131R FcγRIV    
 Fcγ RIIb CD32b Inhibitory Low/Mod ITIM (integral) 232I 232T FcγRIIb  
 Fcγ RIIc CD32c Activatory Low/Mod ITAM (integral)        
 Fcγ RIIIa CD16a Activatory Low/Mod ITAM (associated γ-chain) 158V 158F FcγRIII    
 Fcγ RIIIb CD16b Activatory Low/Mod Non-signalling (gpi-linked) NA1 NA2          
                       
Mouse
 FcγRI   Activatory High ITAM (associated γ-chain)          
 FcγRIIb   Inhibitory Low/Mod ITIM (integral)      
 FcγRIII   Activatory Low/Mod ITAM (associated γ-chain)      
 FcγRIV   Activatory Low/Mod ITAM (associated γ-chain)        

Abbreviations: DC=dendritic cell; ITAM=immunoreceptor tyrosine-based activatory motif; ITIM=immunoreceptor tyrosine-based inhibitory motif; mΦ=macrophage; N=neutrophil, B=B cell; NK=natural killer cell.

a

Fc-receptor expression is variable and can be modulated on certain cell populations, for example, by cytokine signalling and activation status. Data shown are intended to indicate expression on key effector-cell populations involved in Fc-mediated immune responses.

b

Human and murine FcγRI have high affinity for monomeric IgG irrespective of antigen binding.

HHS Vulnerability Disclosure